Minervax ApS   Report issue

For profit Phase 1 Phase 2
Founded: Hellerup Denmark (2010)

Organization Overview

First Clinical Trial
2015
NCT02459262
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Minervax ApS